Clinical Significance of Expression of MMP-3 and MMP-9 in Joint Fluid of Patients with Temporomandibular Disorder

Jian-lin LIU,Yan-song WANG,Mei-jie LIU,Si-ying ZHOU,Xi CHEN
DOI: https://doi.org/10.13241/j.cnki.pmb.2017.06.030
2017-01-01
Abstract:Objective:To study the level change and clinical significance of matrix metalloproteinase-3 (MMP-3) and matrix metalloproteinase-9 (MMP-9) in the joint fluid of patients with temporomandibular disorder,to provide basis for clinical diagnosis and treatment.Methods:60 cases of temporomandibular disorders who were treated in our hospital from April 2013 to April 2016 were selected,they were divided into inflammatory disease group (n=21),structural disorder group (n=l 8),bone and joint disease group(n=21 cases) according to the degree of patient's disease,during the same period 30 cases of healthy volunteers were selected as control group,collected joint fluid samples of the researchers.The levels of MMP-3 and MMP-9 were detected by double antibody sandwich enzyme linked immunosorbent assay.Results:The levels of MMP-3 and MMP-9 in the bone and joint disease group was significantly higher than that of structure disorder group,inflammatory diseases group and control group,which of structural disorder group and inflammatory diseases group were significantly higher than those in the control group,the differences were statistically significant (P<0.05),there was no significant difference between the structural disorder group and inflammatory diseases group (P>0.05).Conclusion:The level of MMP-3 and MMP-9 in joint fluid increases significantly with the degree of lesion,which can reflect the severity of temporomandibular disease.
What problem does this paper attempt to address?